Cargando…
Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
Using lentiviral technology, we recently demonstrated that incorporation of CD27 costimulation into CARs greatly improves antitumor activity and T cell persistence. Still, virus-mediated gene transfer is expensive, laborious and enables long-term persistence, creating therapies which cannot be easil...
Autores principales: | Schutsky, Keith, Song, De-Gang, Lynn, Rachel, Smith, Jenessa B., Poussin, Mathilde, Figini, Mariangela, Zhao, Yangbing, Powell, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745700/ https://www.ncbi.nlm.nih.gov/pubmed/26359629 |
Ejemplares similares
-
Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
por: Song, De-Gang, et al.
Publicado: (2016) -
High affinity FRβ-specific CAR T cells eradicate AML and normal yeloid lineage without HSC toxicity
por: Lynn, Rachel C, et al.
Publicado: (2016) -
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
por: Song, De-Gang, et al.
Publicado: (2015) -
Feasibility and safety of cCD20 RNA CAR-bearing T cell therapy for the treatment of canine B cell malignancies
por: Smith, Jenessa B, et al.
Publicado: (2015) -
Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy
por: Roy, Allison G., et al.
Publicado: (2021)